click here for the university of warwick website click here for warwick ventures website
NEWS


Warwick Ventures Limited is Go!

We are proud to announce that Warwick Ventures Limited [company number: 07293167] is now open for business! after a decade of helping University of Warwick researchers commercialise their research, the University of Warwick's technology transfer office has now a become a spin-out company in its own right. Warwick Ventures Ltd's Director Dr Ederyn Williams said: "In 10 years we have made over 100 patent applications, founded 49 companies and raised over £30 million in funding for those companies from venture capitalists and business angels. "That was achieved simply as an office within the University. "As a company in our own right we can empathise even more with the companies we create and the partners we seek for them and win not just more respect but more funding and more opportunism to create new knowledge based businesses."

Our out-going Chairman, Kevin Gamble. Thank You!

After several years hard work behind the scenes, we would like to take this opportunity to thank our out-going Chairman, Kevin Gamble, for his hard work and enthusiasm in launching Warwick Ventures Ltd. Kevin was not able to stay on the University's Audit Commmittee and be Chairman of Warwick Ventures, so has reluctantly handed over the reins to John Edwards.

New Appointments at Warwick Ventures

In recognition of our new status as a subsidiary company of the University of Warwick, we have brought in some valuable additions to our team:

John Edwards
Non-Executive Chairman

Leading finance expert John Edwards has joined the recently launched Warwick Ventures Ltd. as its new chairman. Mr Edwards was formerly Director General, Finance, of the Department for Business, Enterprise and Regulatory Reform (now Business, Innovation and Skills) prior to his retirement from full time employment in 2009. Before that he has served as Group Finance Director of four major British companies, Jaguar, Northern Electric, Meyer and BNFL, overseeing major business developments in each company during tenures spanning nearly 30 years.

Rob Sprawson
Chief Financial & Commercial Officer

Rob has more than 15 years of professional and commercial experience providing strategic financial advice to Boards and shareholders, especially in the life science and technology industries, to maximise share value. From 2005 to 2009 Rob was the Chief Financial Officer of an AIM listed biotechnology company and prior to that he worked in the Corporate Finance department of PricewaterhouseCoopers LLP, both in Cambridge, UK and Melbourne, Australia.

Dr. Sam Gallagher
Business Development Manager

Sam Gallagher started her career as an MRC post-doctoral Research Fellow working in drug discovery and particle research in lungs. In 1999 she moved into Industry at Amersham Biosciences, then GE Healthcare as a Senior Scientist involved in the imaging platform development for cellular biology and high throughput screening. Following several years in Australia working as Director of R&D for Biopharmica Ltd, then as CEO for their spin-out company Molecular Discovery Systems, Sam moved back to the UK to take up a post as a senior consultant for Isis Enterprise, a consultancy division of Isis Innovation Ltd., the technology transfer office of the University of Oxford.

Dr. Shum Prakash
Just a quick note of congratulations to our colleague, Dr. Prakash, who has successfully completed her MBA at Warwick Business School for which she was awarded a Sainsbury Management Fellowship.

Enterprise Champions

Other notable activity in Warwick Ventures is marked with our long-planned lauch of our Enterprise Chamions Programme. In part to mark our transition to a separate limited company, we have appointed four prominent Warwick academics who have succeeded in both research and enterprise, as "Enterprise Champions". These Enterprise Champions will advise Warwick Ventures on how best to work with researchers and help academic staff understand the advantages and key issues in commercial exploitation of research innovations.

Prof. David Haddleton
(Chemistry)
read more...
Dr. Steve Dixon
(Physics)
read more...
Prof. David Hutchins
(Engineering)
read more...
Prof. Nick Dale
(Life Sciences)
read more...


We look forward to inviting more of our entrepreneurial academics to become Enterprise Champions in the new Year. As we grow, and our remit becomes potentially more and more diverse, the work of our Champions will be central to the way in which we stimulate interest in our work at the grass roots of our academic staff and keep at front-of-mind the drive for technology transfer.


Company Formation: Anvil Semiconductors Ltd

Warwick Ventures is proud to announce its latest company formation; Anvil Semiconductors [Company No. 07300225]. It plans to be the leading supplier of IP to the SiC power semiconductor device manufacturing industry, working in many partnerships with existing and new SiC players. As such it will be responsive to the power system application industry and the mass producers. In order to be credible Anvil will market its skills across the spectrum of substrate manufacturing via device architectures to device manufacturing and plans to have a modest facility for prototyping devices and building high-value niche ultra-high voltage devices.

Warwick Ventures supports Tech Transfer at EU level

Warwick Ventures Business Development Manager Shum Prakash was recently invited to the European Parliament to give her views on how the EU can better support technology transfer activities. Dr Prakash spoke at a workshop organised by the Science and Technology Options Assessment (STOA), the body that advises the European Parliament on the impact of science and technology on EU policy. As part of a wider study conducted by the policy consultants Technopolis, the workshop aimed to give some insights into current issues and trends surrounding technology transfer in higher education and to offer some recommendations on how EU policy in this area might be improved. Dr Prakash was speaking alongside Professor Koen Debackere, of KU Leuven, in the Netherlands, Clive Rowland, CEO of the University of Manchester Intellectual Property Ltd., and Erik Arnold, of Technopolis Group. Results and recommendations from the workshop will inform the next stage of the work to be carried out by Technopolis.

SMALL PRINT

About Us Warwick Ventures is the technology transfer office at the University of Warwick. We exist to enhance the reputation of the University of Warwick, by demonstrating that the University makes good use of IP arising from publicly funded research, for the benefit of the academics, the University and the region and country as a whole; and to generate additional revenues from the exploitation of the research and expertise of the University, making a significant contribution to the finances of the University in the medium to long term.
Subscribe If you would like to subscribe to this newsletter, please click here. Alternatively, if you would like to unsubscribe please see the link at the bottom of this email.
Privacy Policy We guarantee that we will not give the names or email addresses of subscribers to any third party unless required to do so by law.
Editorial Press releases and other information can be sent to the editorial team at ventures@warwick.ac.uk
Disclaimer The material set out here is provided for information purposes only. Warwick Ventures does not take any responsibility for the accuracy of the information provided. Before making any investment decision, potential investors should consult their own professional advisors.